MedTrace Logo

Sexual Function and Quality of Sexual Life in Women With Physical Disabilities

NCT07042646 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-06-29

No results posted yet for this study

Summary

This pilot randomized controlled trial will be carried out with women with physical disabilities registered at a disability center. A total of 49 participants will be randomly assigned to either the intervention group or the control group. Following a three-week follow-up period, the study will be completed, with a total of 26 participants: 16 in the intervention group and 10 in the control group . SRH training will be provided to the intervention group once a week, for a total of three sessions. At the beginning and end of the study, both groups will be administered a survey including demographic information, the Sexual Quality of Life Questionnaire-Female (SQLQ-F), and the Female Sexual Function Index (FSFI).

Conditions

  • Disability Physical

Interventions

BEHAVIORAL

Sexual and Reproductive Health Training program

'The Sexual and Reproductive Health education program was prepared by researchers who are experts in the field of public health and public health nursing. The program was implemented once a week for 3 weeks (why 3 weeks) in 50-60 minute sessions (Table 1). The content and duration of the application were prepared in accordance with the Ministry of Health Sexual and Reproductive Health: National Strategic Action Plan for the Health Sector (2005-2015) and the Turkey Reproductive Health Program Sexual and Reproductive Health Service Standards (2007). Each program session was two education sessions, and all the questions of the disabled woman were answered .

Sponsors & Collaborators

  • Amasya University

    lead OTHER

Principal Investigators

  • zehra incedal sonkaya, PhD · Amasya University

  • murat yücel, PhD · Amasya University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-14
Primary Completion
2024-10-14
Completion
2025-03-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07042646 on ClinicalTrials.gov